Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001691479-18-000001
Filing Date
2018-08-24
Accepted
2018-08-24 13:08:21
Documents
1
Effectiveness Date
2018-08-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11725
  Complete submission text file 0001691479-18-000001.txt   12797
Mailing Address 1616 EASTLAKE AVE E. SUITE 200 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E. SUITE 200 SEATTLE WA 98102 206-957-7300
ApoGen Biotechnologies, Inc. (Filer) CIK: 0001691479 (see all company filings)

EIN.: 471760599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-275911 | Film No.: 181036484